Evidence map›Paper›PMID 36897911›Full record

ArticlePLoS computational biology2023

OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancer.

Anni S Halkola, Kaisa Joki, Tuomas Mirtti, Marko M Mäkelä, Tero Aittokallio, Teemu D Laajala

Full text read
In one paragraph

Article in PLoS computational biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anni S HalkolaDepartment of Mathematics and Statistics, University of Turku, Turku, Finland.
Kaisa JokiDepartment of Mathematics and Statistics, University of Turku, Turku, Finland.
Tuomas MirttiResearch Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Marko M MäkeläDepartment of Mathematics and Statistics, University of Turku, Turku, Finland.
Tero AittokallioDepartment of Mathematics and Statistics, University of Turku, Turku, Finland.ORCID 0000-0002-0886-9769
Teemu D LaajalaDepartment of Mathematics and Statistics, University of Turku, Turku, Finland.ORCID 0000-0002-7016-7354

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In many real-world applications, such as those based on electronic health records, prognostic prediction of patient survival is based on heterogeneous sets of clinical laboratory measurements. To address the trade-off between the predictive accuracy of a prognostic model and the costs related to its clinical implementation, we propose an optimized L0-pseudonorm approach to learn sparse solutions in multivariable regression. The model sparsity is maintained by restricting the number of nonzero coefficients in the model with a cardinality constraint, which makes the optimization problem NP-hard. In addition, we generalize the cardinality constraint for grouped feature selection, which makes it possible to identify key sets of predictors that may be measured together in a kit in clinical practice. We demonstrate the operation of our cardinality constraint-based feature subset selection method, named OSCAR, in the context of prognostic prediction of prostate cancer patients, where it enables one to determine the key explanatory predictors at different levels of model sparsity. We further explore how the model sparsity affects the model accuracy and implementation cost. Lastly, we demonstrate generalization of the presented methodology to high-dimensional transcriptomics data.

Indexed as

AlgorithmsProstatic NeoplasmsGene Expression ProfilingHumansMalePrognosis

Identifiers

PMID36897911
PMCPMC10032505

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read16
identifiers read13
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.